[Oral gallbladder contrast agents in liver damage]

Area of Science:

• Hepatology
• Radiology
• Pharmacology

Context:

• Active chronic liver disease presents diagnostic challenges.
• Peroral cholangiography is an imaging technique for the biliary system.
• Evaluating new contrast agents is crucial for patient safety and diagnostic accuracy.

Purpose:

• To assess the safety and efficacy of Jopron acid as a peroral cholangiographic agent.
• To determine the impact of Jopron acid on serum enzymes and bilirubin levels in patients with liver disease.
• To evaluate the feasibility of biliary system radiography in an ambulance setting.

Summary:

• Jopron acid was administered to 21 patients with laparoscopy and biopsy-confirmed active chronic liver disease.
• No significant increase in serum enzymes, bilirubin, or other assessed parameters was observed post-administration.
• The peroral radiographic examination of the biliary system using Jopron acid was deemed safe for patients.

Impact:

• Jopron acid represents a potentially safe new option for peroral cholangiography.
• The findings support the use of Jopron acid in patients with chronic liver diseases.
• Ambulatory biliary system radiography with Jopron acid may enhance patient convenience and accessibility.